Skip to content

Achieve Life Sciences ACHV Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Returns
Return on equity-496.1%-238pp-257.7%-96.6pp-161.1%-41.0pp-120.1%+34.4pp-154.5%
Return on assets-172%-36.1pp-135.9%-31.2pp-104.7%-23.2pp-81.5%+13.3pp-94.8%+42.5pp
Liquidity
Current ratio2.6×-1.8×4.4×-0.8×5.1×-1.5×6.6×+3.1×3.5×-2.0×
Quick ratio2.6×-1.8×4.4×-0.8×5.1×-1.5×6.6×+3.1×3.5×-2.0×
Cash ratio2.4×+0.1×2.3×-1.0×3.3×-2.8×6.1×+4.2×1.8×-0.1×
Leverage
Debt-to-equity0.5×+0.4×0.2×+0.1×0.0×-0.1×0.1×+0.1×
Debt-to-assets0.2×+0.1×0.1×+0.1×0.0×0.0×0.0×
Per Share
Book value per share$0.20-59.5%$0.49-25.1%$0.66-45.2%$1.20+305%$0.30-54.5%
Valuation
Market capitalization$585.16M+404%$264.57M+64.4%$160.98M+21.8%$132.15M+42.7%$92.61M-23.5%
Enterprise value$562.71M+439%$247.41M+89.8%$130.33M+59.8%$81.58M+0.8%$80.9M-25.4%
Price / book54.8×+43.5×12.3×+7.5×4.8×+1.6×3.2×-5.8×+3.2×
Earnings yield-8.9%+30.8pp-20.7%+11.9pp-32.5%+5.6pp-38.2%+11.7pp-49.8%-16.9pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Achieve Life Sciences's ratios come from?
Every ratio is computed from Achieve Life Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.